Evidence map›Paper›PMID 30355500›Full record

ArticleCell reports2018

Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes.

Jeffrey R Jones, Linghai Kong, Michael G Hanna, Brianna Hoffman, Robert Krencik, Robert Bradley, Tracy Hagemann, Jeea Choi, Matthew Doers, Marina Dubovis and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The intermediate filament protein GFAP regulates mitochondrial fission in astrocytes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Neuroglial Pathophysiology of Leukodystrophies.Advances in neurobiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Alexander disease: the road ahead.Neural regeneration research · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Jeffrey R JonesWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA; Molecular and Cellular Pharmacology Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA.
Linghai KongWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Michael G HannaMolecular and Cellular Pharmacology Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Brianna HoffmanWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Robert KrencikWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Robert BradleyWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Tracy HagemannWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Jeea ChoiDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53706, USA.
Matthew DoersWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Marina DubovisWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Mohammad Amin SherafatWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Anita BhattacharyyaWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Christina KendziorskiDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53706, USA.
Anjon AudhyaMolecular and Cellular Pharmacology Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Albee MessingWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.
Su-Chun ZhangWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA; Department of Neurology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA; Program in Neuroscience & Behavioral Disorders, Duke-NUS Medical School, Singapore, Singapore. Electronic address: suchun.zhang@wisc.edu.
University of Wisconsin–Madison · USDuke-NUS Medical School · SG

Funding

Summer Research ExperienceP50MH100031 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI DAVIDSON, RICHARD J · 2013 to 2017
$10.4M
Waisman Intellectual and Developmental Disabilities Research Center Down Syndrome RegistryU54HD090256 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 2016 to 2020
$6.0M
Patient-derived iPS cells as model systems for AxDP01HD076892 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI NEDERGAARD, MAIKEN · 2014 to 2018
$6.0M
Individualized Cell Therapy for Parkinson's DiseaseR01NS076352 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2012 to 2016
$3.1M
Reconstruction and Regulation of Neural Circuitry by Human NeuronsR01NS096282 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2017 to 2021
$1.7M
Transgenic Human Stem Cell Lines and ReagentsR24NS086604 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2014 to 2017
$1.1M
Development and function of human astrocytesR01MH099587 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI ZHANG, SU-CHUN · 2013 to 2015
$858k
NICHD NIH HHS P01 HD076892NICHD NIH HHS U54 HD090256NIMH NIH HHS P50 MH100031NIMH NIH HHS R01 MH099587NINDS NIH HHS R01 NS076352NINDS NIH HHS R01 NS096282NINDS NIH HHS R24 NS086604
6 · The paper itself

Abstract

How mutations in glial fibrillary acidic protein (GFAP) cause Alexander disease (AxD) remains elusive. We generated iPSCs from two AxD patients and corrected the GFAP mutations to examine the effects of mutant GFAP on human astrocytes. AxD astrocytes displayed GFAP aggregates, recapitulating the pathological hallmark of AxD. RNA sequencing implicated the endoplasmic reticulum, vesicle regulation, and cellular metabolism. Corroborating this analysis, we observed enlarged and heterogeneous morphology coupled with perinuclear localization of endoplasmic reticulum and lysosomes in AxD astrocytes. Functionally, AxD astrocytes showed impaired extracellular ATP release, which is responsible for attenuated calcium wave propagation. These results reveal that AxD-causing mutations in GFAP disrupt intracellular vesicle regulation and impair astrocyte secretion, resulting in astrocyte dysfunction and AxD pathogenesis.

Indexed as

Adenosine TriphosphateAlexander DiseaseAnimalsAstrocytesCalcium SignalingCell DifferentiationEndoplasmic ReticulumGlial Fibrillary Acidic ProteinHumansLysosomesMiceMutationOrganellesProtein AggregatesRNA, MessengerAdenosine TriphosphateGlial Fibrillary Acidic ProteinProtein AggregatesRNA, MessengerAlexander diseaseCRISPRendoplasmic reticulumiPSClysosome

Identifiers

PMID30355500
PMCPMC6275075
OpenAlexW2897195504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.